$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Teritusumab/Telicot use contraindications and unwell populations
2026-02-01 22:25:32
Check Details
Comprehensive description of common side effects and safety risks of ivonib (Tosovo)
2026-02-01 22:25:32
Check Details
What is the reference price of Mitotane at Peking Union Medical College Hospital?
2026-02-01 22:25:32
Check Details
Is Pemetinib (Dabotan) a targeted drug treatment?
2026-02-01 22:25:32
Check Details
Introduction to the formal purchasing channels of Erdafitinib (Bocco) and comparison of drug purchasing methods at home and abroad
2026-02-01 22:25:32
Check Details
The relationship between Erlotinib and Lorit and the differences between different packaging versions
2026-02-01 22:25:32
Check Details
The main contents, usage, dosage and precautions of the official instructions of Tofacitinib (Shangjie)
2026-02-01 22:25:32
Check Details
A comprehensive introduction to the possible side effects and risks of cycloserine during long-term use
2026-02-01 22:25:32
Check Details
How many times a day should linezolid (Siwo) tablets 600 mg be taken to meet the standard dosage requirements?
2026-02-01 22:25:32
Check Details
Whether ribociclib (Calilon) is strictly a targeted drug and a detailed analysis of its CDK4/6 inhibition mechanism
2026-02-01 22:25:32
Check Details
Is cemiplimab available in China and the status of its listing and channel availability in China
2026-02-01 22:25:32
Check Details
The latest progress of Daprodustat as well as global marketing trends and clinical research directions
2026-02-01 22:25:32
Check Details
1
2
...
2416
2417
2418
2419
2420
2421
2422
...
10214
10215
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
LONSURF® (Trifluridine/Tipiracil): Unveiling the Global R&D and Supply Chain Behind the Oral Chemotherapy
2
Breaking the Bottleneck: KOSELUGO® (Selumetinib) Reshapes the Treatment Landscape for Neurofibromatosis Type 1 (NF1)
3
FDA Approves Lilly's Inluriyo (Imlunestrant) for ESR1-Mutant Advanced Breast Cancer
4
Niraparib: A PARP Inhibitor for Ovarian Cancer Maintenance Therapy
5
Abiraterone Acetate: CYP17 Inhibitor for Advanced Prostate Cancer
6
Plerixafor: Mobilizing Hematopoietic Stem Cells for Autologous Transplantation
7
Brensoctib: Managing Side Effects of the Novel DPP-1 Inhibitor for Bronchiectasis
8
Tivozanib: The Evolution of Highly Selective VEGFR Inhibition in Renal Cell Carcinoma
9
Trifluridine/Tipiracil: Managing Side Effects in Metastatic Colorectal and Gastric Cancer
10
Trelagliptin: The First Once-Weekly DPP-4 Inhibitor Revolutionizing Type 2 Diabetes Care
11
Adagrasib Medication Management Guide for Special Populations
12
Olutasidenib (Rezlidhia): A Targeted Drug for IDH1-Mutated Relapsed/Refractory AML